Lauxera Capital completed a €23m investment in Antaros Medical and Antaros Tracer.

Lauxera Capital, a private equity firm, completed a €23m investment in Antaros Medical, a Swedish strategic development partner for the pharmaceutical industry, and Antaros Tracer, a sister company of Antaros Medical. Financial terms were not disclosed. “Advanced imaging methods like those pioneered by Antaros are becoming instrumental to drug development, especially as all stakeholders embrace precision medicine as the answer to improving the efficiency of therapeutic innovation. We are proud to support Antaros and its outstanding founders and management team as They build a science-first, consultative partner to innovative biopharmas, a goal fully aligned with Lauxera’s mission to enable a more sustainable healthcare system and to deliver measurable impact for patients, providers, and payors alike,” Alex Slack, Lauxera Capital Co-Founding Partner.